108605
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
Ti3C2Tx MXene 通过 miR-665/GSK-3β/β-连环蛋白轴增强 PSAT1 介导的成骨作用以对抗炎症诱导的骨质流失
Authors Zhang J, Wang X, Xiao J, Hong H, Chen J, Wu C, Xu G, Cui Z
Received 9 March 2025
Accepted for publication 15 August 2025
Published 12 September 2025 Volume 2025:20 Pages 11151—11168
DOI https://doi.org/10.2147/IJN.S521957
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. RDK Misra
Jinlong Zhang,1,2,* Xinyang Wang,3,4,* Jingwen Xiao,5,* Hongxiang Hong,1,2 Jiajia Chen,1,2 Chunshuai Wu,1,2 Guanhua Xu,1,2 Zhiming Cui1,2
1Department of Spine Surgery, Nantong City No.1 People’s Hospital and Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, 226001, People’s Republic of China; 2Research Institute for Spine and Spinal Cord Disease of Nantong University, Nantong, Jiangsu, 226014, People’s Republic of China; 3Department of Stomatology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, 226001, People’s Republic of China; 4Department of Stomatology, Zhenjiang 359 Hospital, Zhenjiang, Jiangsu Province, 212000, People’s Republic of China; 5Department of Stomatology, Haimen District People’s Hospital, Nantong, Jiangsu Province, 226100, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhiming Cui, Department of Spine Surgery, Nantong City No.1 People’s Hospital and Second Affiliated Hospital of Nantong, Nantong, Jiangsu Province, 226001, People’s Republic of China, Email czmspine@ntu.edu.cn Guanhua Xu, Department of Spine Surgery, Nantong City No.1 People’s Hospital and Second Affiliated Hospital of Nantong, Nantong, Jiangsu Province, 226001, People’s Republic of China, Email xghspine@163.com
Introduction: Inflammatory signaling-induced stem cell dysfunction severely impairs bone regeneration. This study aimed to develop a combinatorial strategy using Ti3C2Tx MXene scaffolds and PSAT1-engineered dental pulp stem cells (oe-PSAT1 DPSCs) to counteract inflammation-mediated osteogenic suppression.
Methods: Dental pulp stem cells (DPSCs) were treated with TNF-α to simulate an inflammatory microenvironment. miR-665 expression and its targeting relationship with PSAT1 were analyzed via qRT-PCR, dual-luciferase reporter assay, and Western blot. The role of the miR-665/PSAT1/GSK-3β/β-catenin axis in osteogenic differentiation was evaluated using ALP activity, alizarin red staining, and immunofluorescence. Ti3C2Tx MXene was synthesized and characterized, and its effects on ROS scavenging and osteogenesis were assessed in vitro. In vivo efficacy was validated using a rat calvarial defect model with micro-CT, histological staining, and immunohistochemistry.
Results: TNF-α stimulation upregulated miR-665, which directly targeted PSAT1 and inhibited the GSK-3β/β-catenin pathway, suppressing DPSCs osteogenic differentiation. PSAT1 overexpression rescued this suppression. Ti3C2Tx MXene scavenged ROS, enhanced calcium-dependent mineralization, and synergized with oe-PSAT1 DPSCs to amplify β-catenin activation. In rat models, the Ti3C2Tx MXene /oe-PSAT1 DPSCs combination achieved superior bone defect closure (higher BV/TV, Tb. Th, and mature collagen deposition) compared to Ti3C2Tx MXene alone.
Discussion: This study identifies the miR-665/PSAT1/GSK-3β/β-catenin axis as a key regulator of inflammatory osteogenesis. The Ti3C2Tx MXene/oe-PSAT1 DPSCs strategy concurrently neutralizes oxidative stress and activates osteogenic signaling, providing a translatable platform for inflammatory bone regeneration.
Keywords: DPSCs, osteogenic differentiation, miR-665, PSAT1, Ti3C2Tx
1Department of Spine Surgery, Nantong City No.1 People’s Hospital and Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, 226001, People’s Republic of China; 2Research Institute for Spine and Spinal Cord Disease of Nantong University, Nantong, Jiangsu, 226014, People’s Republic of China; 3Department of Stomatology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, 226001, People’s Republic of China; 4Department of Stomatology, Zhenjiang 359 Hospital, Zhenjiang, Jiangsu Province, 212000, People’s Republic of China; 5Department of Stomatology, Haimen District People’s Hospital, Nantong, Jiangsu Province, 226100, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhiming Cui, Department of Spine Surgery, Nantong City No.1 People’s Hospital and Second Affiliated Hospital of Nantong, Nantong, Jiangsu Province, 226001, People’s Republic of China, Email czmspine@ntu.edu.cn Guanhua Xu, Department of Spine Surgery, Nantong City No.1 People’s Hospital and Second Affiliated Hospital of Nantong, Nantong, Jiangsu Province, 226001, People’s Republic of China, Email xghspine@163.com
Introduction: Inflammatory signaling-induced stem cell dysfunction severely impairs bone regeneration. This study aimed to develop a combinatorial strategy using Ti3C2Tx MXene scaffolds and PSAT1-engineered dental pulp stem cells (oe-PSAT1 DPSCs) to counteract inflammation-mediated osteogenic suppression.
Methods: Dental pulp stem cells (DPSCs) were treated with TNF-α to simulate an inflammatory microenvironment. miR-665 expression and its targeting relationship with PSAT1 were analyzed via qRT-PCR, dual-luciferase reporter assay, and Western blot. The role of the miR-665/PSAT1/GSK-3β/β-catenin axis in osteogenic differentiation was evaluated using ALP activity, alizarin red staining, and immunofluorescence. Ti3C2Tx MXene was synthesized and characterized, and its effects on ROS scavenging and osteogenesis were assessed in vitro. In vivo efficacy was validated using a rat calvarial defect model with micro-CT, histological staining, and immunohistochemistry.
Results: TNF-α stimulation upregulated miR-665, which directly targeted PSAT1 and inhibited the GSK-3β/β-catenin pathway, suppressing DPSCs osteogenic differentiation. PSAT1 overexpression rescued this suppression. Ti3C2Tx MXene scavenged ROS, enhanced calcium-dependent mineralization, and synergized with oe-PSAT1 DPSCs to amplify β-catenin activation. In rat models, the Ti3C2Tx MXene /oe-PSAT1 DPSCs combination achieved superior bone defect closure (higher BV/TV, Tb. Th, and mature collagen deposition) compared to Ti3C2Tx MXene alone.
Discussion: This study identifies the miR-665/PSAT1/GSK-3β/β-catenin axis as a key regulator of inflammatory osteogenesis. The Ti3C2Tx MXene/oe-PSAT1 DPSCs strategy concurrently neutralizes oxidative stress and activates osteogenic signaling, providing a translatable platform for inflammatory bone regeneration.
Keywords: DPSCs, osteogenic differentiation, miR-665, PSAT1, Ti3C2Tx